Skip to main content
← All Companies
Abridge logo

Abridge

AI Native
AI Classification
AI is foundational, and the product wouldn't exist without it.

Clinical AI documentation leader raises $150M to revolutionize healthcare note-taking

Total Funding

$550M

Founded

2018

Headquarters

Pittsburgh, United States

Industry Vertical

Health & Biotech

Technology Segments

Clinical Decision SupportDocument AutomationSpeech RecognitionAI Agents

About

Abridge develops artificial intelligence solutions focused on transforming healthcare documentation by converting patient-clinician conversations into structured clinical notes in real time. Its platform seamlessly integrates with electronic health records, aiming to reduce clinician workload, increase documentation accuracy, and improve the overall quality of care delivery. Abridge’s technology is widely adopted by health systems, supporting conversations across numerous medical specialties and languages.

The company’s mission is to enhance care experiences for both patients and providers through cutting-edge AI-driven workflow automation.

Funding Rounds

2
DateRoundAmount
2025-06-24Series E$300M
2025-02-17Series D$250M

Investors

14
Andreessen HorowitzKhosla VenturesElad GilIVPBessemer Venture PartnersCalifornia Health Care FoundationCapitalGCVS Health VenturesK. VenturesLightspeed Venture PartnersNVenturesRedpoint VenturesSpark CapitalSV Angel

Subscribe to Monday AI Signal

Weekly pre-seed and seed AI deal intelligence with early trends.